Back to Search
Start Over
Corrigendum to "Safety and immunogenicity of mRNA-LNP COVID-19 vaccine CVnCoV in Latin American adults: A phase 2 randomized study" [Vaccine: X 11 (2022) 100189].
- Source :
-
Vaccine: X [Vaccine X] 2023 Aug; Vol. 14, pp. 100307. Date of Electronic Publication: 2023 Apr 28. - Publication Year :
- 2023
-
Abstract
- [This corrects the article DOI: 10.1016/j.jvacx.2022.100189.].<br /> (© 2023 The Author(s).)
Details
- Language :
- English
- ISSN :
- 2590-1362
- Volume :
- 14
- Database :
- MEDLINE
- Journal :
- Vaccine: X
- Accession number :
- 37131960
- Full Text :
- https://doi.org/10.1016/j.jvacx.2023.100307